MétaCan
Menu
Back to cohort

Influence of Induction Therapy On the Efficacy of Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients.

2014· article· en· W2775129176 on OpenAlexaboutno aff
F. Vincenti, Yasir Qazi, B. Kaplan, D. Kim, Fuad S. Shihab, Dhaval Patel, S. Mulgaonkar, David R. Shaffer

Bibliographic record

VenueTransplantation · 2014
Typearticle
Languageen
FieldMedicine
TopicRenal Transplantation Outcomes and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsBasiliximabMedicineAnti-thymocyte globulinRegimenCumulative incidenceMycophenolic acidUrologyEverolimusThymoglobulinInduction therapyInternal medicineCalcineurinTransplantationIncidence (geometry)TacrolimusGastroenterologyChemotherapy

Abstract

fetched live from OpenAlex

Introduction: Induction therapy has been shown to lower the risk of acute rejection in renal transplant recipients (RTxR). In this 12-month (M), multicenter (52 US & Canadian centers), randomized, open-label non-inferiority study, we report the outcome by induction therapy (basiliximab vs rabbit anti-thymocyte globulin [rATG]) on the efficacy of everolimus (EVR)+low-dose tacrolimus (LTac) vs mycophenolate mofetil (MMF)+standard-dose Tac (STac) regimen in de novo RTxR. Methods: De novo (n=613) RTxR received EVR (starting dose of 0.75 mg bid)+LTac (n=309) or MMF (2 g/day)+STac (n=304). Induction therapy was based on PRA levels; if PRA<20%, pts received basiliximab (EVR+LTac, n=213; MMF+STac, n=210) and if PRA ≥20% or at high risk (those receiving DCD or ECD) pts received rATG (EVR+LTac, n=96; MMF+STac, n=94). Steroids were administered as per local practice. Composite efficacy failure rate at 12M included tBPAR, graft loss, death, or lost to follow-up. Renal function (eGFR) was estimated at 12M using MDRD formula. Results: HLA mismatches (HLA ≥3) and ECD were more frequent in EVR+LTac group regardless of induction therapy. Induction with rATG resulted in numerically higher composite efficacy failure rates vs basiliximab in both treatment regimens; moreover, the incidence rates of the efficacy endpoints between treatments did not reach the statistical significance (Table). However, in basliliximab induction group, the incidence of tBPAR was significantly higher with EVR+LTac vs MMF+STac (p<0.05); nevertheless, the incidence of graft loss was significantly lower with EVR+LTac vs MMF+STac (p<0.05). At 12M, mean eGFR was comparable in both treatment regimens regardless of induction therapy (Table).Table: No Caption available.Conclusions: Composite efficacy failure rate was higher in the rATG group but this did not reach statistical significance. Regardless of induction therapy the graft and patient survival was high with EVR+LTac (98.7% & 98.1%) and MMF+STac (96.1% & 98.4%) at 1 year. DISCLOSURES:Vincenti, F.: Grant/Research Support, Novartis, Genzyme, Genentech, Astellas, Alexion, Pfizer. Shihab, F.: Other, Novartis, Consultant and Speaker, Astellas, Consultant. McCague, K.: Employee, Novartis Pharmaceuticals Corporation. Patel, D.: Employee, Novartis Pharmaceuticals Corporation. Mulgaonkar, S.: Grant/Research Support, Novartis, Other, Novartis, Advisor. Shaffer, D.: Grant/Research Support, Novartis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.260
Threshold uncertainty score0.416

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.280
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueTransplantationSame topicRenal Transplantation Outcomes and TreatmentsFrench-language works237,207